BlackRock Virginia Municipal Bond Trust (BHV) Stock Price

10.71 ▲ +0.04 (+0.37%)
Open: 10.6875 Vol: 5.89K Day's range: 10.6875 - 10.73 Feb 06, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
BHV Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 10.58▲ 10.58▲ 10.58▲ 10.67▲ 10.60▲
MA10 10.59▲ 10.59▲ 10.59▲ 10.60▲ 10.67▲
MA20 10.58▲ 10.62▲ 10.62▲ 10.58▲ 10.88▼
MA50 10.91▼ 10.94▼ 10.94▼ 10.70▲ 10.60▲
MA100 10.80▼ 10.71▼ 10.72▼ 10.85▼ 10.85▼
MA200 10.83▼ 10.88▼ 10.87▼ 10.58▲ 11.16▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.028▲ 0.022▲ 0.021▲ 0.030▲ -0.048▼
RSI 49.895▼ 49.090▼ 48.977▼ 57.791▲ 49.818▼
STOCH 45.718     45.718     45.718     91.321▲ 34.323    
WILL %R 0.000▲ 0.000▲ 0.000▲ -7.133▲ -62.914    
CCI 137.920▲ 137.920▲ 137.920▲ 141.561▲ -35.426    
Latest Filters Detected On BHV
▲ MA $BHV MA(20) Crossed Above MA(200) Set Alert
MA $BHV Price Crossed Above MA(50) Set Alert
▲ BREAK $BHV Price Breaks 20 Days High Set Alert
▲ BREAK $BHV Price Breaks 10 Days High Set Alert
BlackRock Virginia Municipal Bond Trust News
Biohaven Highlights Portfolio Progress, Positive Early Patient Data from Priority Degrader Programs and Anticipated Milestones at the 44th Annual J.P. Morgan Healthcare Conference
Monday, January 12, 2026 08:15 AM
Reports positive early clinical experience from first and only clinically validated, extracellular protein degraders using Biohaven's proprietary MoDE™ and next-generation, highly selective TRAP™ ...
Biohaven Misses The Mark In Depression Trial, Stock Falls
Friday, December 26, 2025 12:20 AM
On Wednesday, Biohaven Ltd. (NYSE: BHVN) reported results from a Phase 2 proof-of-concept study evaluating BHV-7000 for major depressive disorder (MDD). The study did not meet its primary endpoint, a ...
Biohaven: Phase 2 Proof-of-concept Study With BHV-7000 Fails To Meet Primary Endpoint
Thursday, December 25, 2025 03:26 AM
(RTTNews) - Biohaven (BHVN) reported results from a Phase 2 proof-of-concept study evaluating BHV-7000 for the treatment of major depressive disorder. The study did not meet its primary endpoint, a ...
BHV historical stock data
date open high low close volume
06/02/26 10.6875 10.73 10.6875 10.71 5,889
05/02/26 10.67 10.67 10.6532 10.67 11,685
04/02/26 10.60 10.68 10.60 10.64 3,600
03/02/26 10.67 10.67 10.65 10.66 7,112
02/02/26 10.65 10.65 10.65 10.65 1,840
30/01/26 10.55 10.6172 10.545 10.5873 4,435
29/01/26 10.515 10.53 10.515 10.53 860
28/01/26 10.54 10.5401 10.515 10.5401 10,508
27/01/26 10.48 10.57 10.4799 10.5255 10,469
26/01/26 10.46 10.489 10.4496 10.46 10,645
Quote Details
52wk Low:10.01
52wk High:11.66
Vol:5.89K
Avg Vol(3m):109.6K
1Y Chng:-1.74%
1M Chng:+1.81%
Add to Watch List
More Information
Index N/A
Market Cap. 16.95M